Andere talen Dicot AB

Aandelen

slotkoers NORDIC GROWTH MARKET Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,2495 ^SEK	+4,83%		+19,09%	-21,54%

23/04	Dicot AB (publ) kondigt positieve resultaten aan op het gebied van veiligheid en verbeterde werkzaamheid van fase 1-onderzoek	CI
11/03	Dicot AB (publ) kondigt aan dat de werving voor het fase 1 onderzoek van Dicot is voltooid	CI

Good safety and improved erectile function reported from Dicot's phase 1 study	23/04
Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study	23/04
Dicot in preparation for clinical phase 2a trial	12/04
Reporting from Dicot's phase 1 study end of April	05/04
BioStock: Dicot's phase I study fully recruited	14/03
Recruitment completed in Dicot's phase 1 trial	11/03
Dicot AB Announces Recruitment Completed in Dicot's Phase 1 Trial	11/03
Dicot's CEO tells BioStock: "Several prominent people want to be part of the journey"	29/02
Dicot AB Year-End Report 2023	26/02
Dicot AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	26/02
BioStock: Good safety profile for Dicot's LIB-01	26/01
Positive results from the first part of Dicot's phase 1 study	23/01
Dicot AB Presents Positive Results from the First Part of its Phase 1 Clinical Study	23/01
Dicot Files New Manufacturing Technology Patent in Sweden; Stock Rises	11/01
Dicot applies for patent covering new manufacturing technology	11/01
Dicot Applies for Patent Covering New Manufacturing Technology	11/01
Dicot invited to present at ESSM for the third time	05/01
BioStock: Interim results from Dicot's phase I study to be released earlier than expected	20/12
Partial results from Dicot's phase 1 trial to be presented early next year	15/12
Dicot AB Announces Partial Results from Phase 1 Trial to Be Presented Early Next Year	15/12

Geen resultaten voor deze zoekopdracht